Matthew J. Frigault

Also affiliated with Boston Medical Center, Harvard University, Cambridge Hospital, Massachusetts General Hospital, Dorset County Hospital, Center for Cancer Research, Cellular Research (United States), Dana-Farber Brigham Cancer Center, Mass General Brigham

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 32 papers. Top paper: “Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial”.

Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial

Blood(2022)10.1182/blood.2021014738

N/A

4.5DataRank · unranked

141 citations

Jörg Dietrich, Kathleen Gallagher, Mark Roschewski, Justin T. Jordan, Deborah Forst +22 more

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

Blood Advances(2020)10.1182/bloodadvances.2019000784

N/A

2.0DataRank · unranked

65 citations

Philippe Armand, Robert Redd, Erin Jeter, Reid W. Merryman, Kimberly C. Coleman +21 more

Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors

Frontiers in Oncology(2022)10.3389/fonc.2022.818679

N/A

0.830DataRank · unranked

20 citations

Marcus O. Butler, Russell K. Pachynski, Ryan J. Sullivan, Partow Kebriaei, Sarah Boross-Harmer +20 more

Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract

Blood Advances(2024)10.1182/bloodadvances.2024012556

N/A

0.724DataRank · unranked

23 citations

Ashish Damania, Haesook T. Kim, Chia‐Chi Chang, Areej El‐Jawahri, Steven L. McAfee +20 more

Acute Kidney Injury After the CAR-T Therapy Tisagenlecleucel

American Journal of Kidney Diseases(2020)10.1053/j.ajkd.2020.08.017

N/A

0DataRank · unranked

29 citations

Ian A. Strohbehn, Harish Seethapathy, Nifasha Rusibamayila, Keagan S. Casey, Shruti Gupta +4 more

Reply

Journal of the American College of Cardiology(2020)10.1016/j.jacc.2020.03.045

N/A

0DataRank · unranked

0 citations

Michael G. Fradley, Matthew J. Frigault, Frederick L. Locke, Tomas G. Neilan, Raza M. Alvi

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Leukemia(2021)10.1038/s41375-021-01193-6

N/A

0DataRank · unranked

83 citations

Luca Castagna, Laura Giordano, Vincent T. Ho, Paolo Corradini, Anna Guidetti +61 more

Immune checkpoint inhibitors for cancer and venous thromboembolic events

European Journal of Cancer(2021)10.1016/j.ejca.2021.09.010

N/A

0DataRank · unranked

78 citations

Zsófia D. Drobni, Raza M. Alvi, Sean Murphy, Ryan J. Sullivan, Sarah Hartmann +11 more

A rapid genotyping panel for detection of primary central nervous system lymphoma

Blood(2021)10.1182/blood.2020010137

N/A

0DataRank · unranked

42 citations

Evan Burns, N. Zeke Georgantas, Julia Thierauf, Naema Nayyar, Amanda Gordon +24 more

Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS)

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003847

N/A

0DataRank · unranked

130 citations

Kathleen Gallagher, Yi‐Bin Chen, Mark B. Leick, Steven L. McAfee, Areej El‐Jawahri +11 more

Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac185

N/A

0DataRank · unranked

76 citations

Ambike Aarti Srivastava, Rishab Ramapriyan, Stefanie R. Bailey, Amanda A. Bouffard, Daniel P. Cahill +17 more

Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19

Blood(2022)10.1182/blood.2022018052

N/A

0DataRank · unranked

26 citations

Geoffrey Fell, Brody H. Foy, Allison K. Scherer, Christopher J. Gibson, Adam S. Sperling +16 more

EEG-based grading of immune effector cell-associated neurotoxicity syndrome

Scientific Reports(2022)10.1038/s41598-022-24010-1

N/A

0DataRank · unranked

18 citations

Christine A. Eckhardt, Haoqi Sun, Ryan A. Tesh, Preeti Malik, Syed A. Quadri +16 more

Distinct cellular dynamics associated with response to CAR-T therapy for refractory B-cell lymphoma

medRxiv(2022)10.1101/2022.04.04.22273422

N/A

0DataRank · unranked

20 citations

Mark B. Leick, Katie Maurer, Satyen H. Gohil, Rebecca C. Larson, Ning Yao +22 more

Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.03.006

N/A

0DataRank · unranked

312 citations

Tristan Knight, Kevin O. McNerney, Mark B. Leick, Tania Jain, Sairah Ahmed +26 more

Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients

European Heart Journal(2023)10.1093/eurheartj/ehad117

N/A

0DataRank · unranked

49 citations

Peter A. Riedell, Stephanie Feldman, Gina George, Stephen Sansoterra, Thomas Althaus +29 more

Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma

Nature Communications(2023)10.1038/s41467-023-43416-7

N/A

0DataRank · unranked

45 citations

Michael C. Kann, Charlotte Graham, Christopher Mount, Ana P. Castaño, Won‐Ho Lee +10 more

Respiratory infections predominate after day 100 following B-cell maturation antigen–directed CAR T-cell therapy

Blood Advances(2023)10.1182/bloodadvances.2023010524

N/A

0DataRank · unranked

39 citations

Megha Tandon, Joseph Hong, Omar Nadeem, Adam S. Sperling, Noopur Raje +5 more

Clinical efficacy and safety of chimeric antigen receptor T‐cell therapy for mantle cell lymphoma with secondary central nervous system involvement

British Journal of Haematology(2023)10.1111/bjh.19037

N/A

0DataRank · unranked

16 citations

Rebecca L. Zon, Robert Redd, David C. Fisher, Roni Shouval, Anita Kumar +12 more

Automated detection of immune effector cell‐associated neurotoxicity syndrome via quantitative EEG

Annals of Clinical and Translational Neurology(2023)10.1002/acn3.51866

N/A

0DataRank · unranked

8 citations

Haoqi Sun, Preeti Malik, Syed A. Quadri, Marcos Santana Firme, Daniel Jones +15 more

Data from Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells

(2023)10.1158/2326-6066.c.6548833.v1

N/A

0DataRank · unranked

0 citations

Ji‐Hyun Lee, Maria C. Basil, Carmine Carpenito, Shinichiro Motohashi, John Scholler +14 more

Stealth transgenes enable CAR-T cells to evade host immune responses

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008417

N/A

0DataRank · unranked

16 citations

Trisha R. Berger, Michael C. Kann, Harrison Silva, Rebecca C. Larson, Mark B. Leick +8 more

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?

UNC Libraries(2024)10.17615/h0gs-sd07

N/A

0DataRank · unranked

1 citations

Michael K. Mansour, Zhen‐Huan Hu, Mary M. Horowitz, Peiman Hematti, Miguel‐Angel Perales +6 more

Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis

UNC Libraries(2024)10.17615/d5s2-9s76

N/A

0DataRank · unranked

0 citations

Peter A. Riedell, R. Alejandro Sica, Tania Jain, Brian T. Hill, Craig S. Sauter +24 more

Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-009890

N/A

0DataRank · unranked

14 citations

Matthew J. Frigault, Michael Heim, S.R. Foley, Brian T. Hill, Grant Schofield +14 more

CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.10.024

N/A

0DataRank · unranked

3 citations

Matthew A. Lunning, Mazyar Shadman, Sairah Ahmed, Jeremy S. Abramson, Miguel‐Angel Perales +14 more

365 Single-cell transcriptional profiles of cilta-cel and ide-cel associate with response in multiple myeloma

Regular and Young Investigator Award Abstracts(2025)10.1136/jitc-2025-sitc2025.0365

N/A

0DataRank · unranked

0 citations

Charlotte Graham, Aiyana Parker, Maria Dolaher, Kevin Lindell, Deshea L Harris +16 more

Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma

American Journal of Kidney Diseases(2020)10.1053/j.ajkd.2019.10.011

N/A

0DataRank · unranked

124 citations

Harish Seethapathy, Ian A. Strohbehn, Matthew J. Frigault, Elizabeth O’Donnell, Caron A. Jacobson +7 more

Letter to the EditorTumor-infiltrating lymphocyte therapy generated from melanoma brain metastasis: Proof-of-concept for CNS-derived cellular immunotherapy

Neuro-Oncology(2025)10.1093/neuonc/noaf288

N/A

0DataRank · unranked

0 citations

Samuel J. Steuart, Baolin Liu, Hongyan Xie, Derek Effiom, Aleigha Lawless +18 more

State of the art in CAR T cell therapy for CD19+ B cell malignancies

Journal of Clinical Investigation(2020)10.1172/jci129208

N/A

0DataRank · unranked

105 citations

Marcela V. Maus, Matthew J. Frigault

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?

Blood(2020)10.1182/blood.2020006216

N/A

0DataRank · unranked

67 citations

Sarah Nikiforow, Michael K. Mansour, Zhen‐Huan Hu, Mary M. Horowitz, Marcie Riches +6 more

Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000990

N/A

0DataRank · unranked

29 citations

Leah C Marsh, Ambike Aarti Srivastava, Amanda A. Bouffard, Angela C. Boroughs, Irene Scarfò +13 more